Delivery Order SPE2DB22D2206-SPE2DB25FEA98

Award Date 11/1/24
Potential Completion Date 11/25/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 delivery order contract is for the supply of VENCLEXTA 100 MG TABLET UU 120S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of April 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,187.06 firm fixed price delivery order is for the supply of VENCLEXTA 100 MG Tablets. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 firm-fixed-price delivery order is for the supply of VENCLEXTA 100 MG TABLET UU 120S, a prescription medication. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 firm fixed-price delivery order is for the supply of VENCLEXTA 100 MG TABLET UU 120S, a pharmaceutical product. The contract has an ultimate completion date of April 17, 2025 and was awarded on March 27, 2025. There is no set-aside designation for this contract. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,561.18 Firm Fixed Price Delivery Order is for the supply of Venclexta 100 mg tablets. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $8,554.12 for the supply of VENCLEXTA 100 MG TABLET UU 120S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of April 10, 2023 and is a firm fixed price procurement. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award, valued at $2,289.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product VENCLEXTA 100 MG TABLET UU 28S, with a performance period extending through May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award, valued at $19,456.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription drug Venclexta, a 100 mg tablet, over a period ending on February 12, 2025. This is a firm fixed-price delivery order contract, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,880.15 Firm Fixed Price Delivery Order contract is for the supply of VENCLEXTA 100 MG TABLET UU 120S, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024 and was awarded on November 19, 2024. There is no set-aside designation for this award. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,880.15 Firm Fixed Price Delivery Order contract is for the supply of VENCLEXTA 100 MG TABLET UU 120S, a specialty medication product. The contract has an ultimate completion date of November 15, 2024 and was awarded on October 24, 2024. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEA98
    Delivery Order

This federal contract award, valued at $17,760.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product VENCLEXTA 100 MG TABLET, with a period of performance through November 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies. The contract award did not have a set-aside designation, indicating open competition.

Generated 1/31/25, 9:25 AM